UA10952U - Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome - Google Patents

Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome

Info

Publication number
UA10952U
UA10952U UAU200501042U UAU200501042U UA10952U UA 10952 U UA10952 U UA 10952U UA U200501042 U UAU200501042 U UA U200501042U UA U200501042 U UAU200501042 U UA U200501042U UA 10952 U UA10952 U UA 10952U
Authority
UA
Ukraine
Prior art keywords
microcirculation
hemostasis
patients
insulin resistance
resistance syndrome
Prior art date
Application number
UAU200501042U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Оксана Святославівна Хухліна
Оксана Святославовна Хухлина
Original Assignee
Буковинська Державна Медична Академія Міністерства Охорони Здоров'Я України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Буковинська Державна Медична Академія Міністерства Охорони Здоров'Я України filed Critical Буковинська Державна Медична Академія Міністерства Охорони Здоров'Я України
Priority to UAU200501042U priority Critical patent/UA10952U/en
Publication of UA10952U publication Critical patent/UA10952U/en

Links

Abstract

The method for correcting the disorders of microcirculation and hemostasis in the patients with the chronic steatohepatitis with insulin resistance syndrome comprises the use of the basic therapy supplemented with glutargin, first parenterally and then per os in combination with acetyl cysteine.  
UAU200501042U 2005-02-07 2005-02-07 Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome UA10952U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200501042U UA10952U (en) 2005-02-07 2005-02-07 Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200501042U UA10952U (en) 2005-02-07 2005-02-07 Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome

Publications (1)

Publication Number Publication Date
UA10952U true UA10952U (en) 2005-12-15

Family

ID=74537684

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200501042U UA10952U (en) 2005-02-07 2005-02-07 Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome

Country Status (1)

Country Link
UA (1) UA10952U (en)

Similar Documents

Publication Publication Date Title
NZ591312A (en) Treatment of pediatric acute lymphoblastic leukemia with a CD19 CD3 bispecific single chain antibody construct
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
EP1841781A4 (en) Use of il-22 for the treatment of conditions of metabolic disorders
EA201100958A1 (en) PHARMACEUTICAL ORAL DOSED DOSAGE FORM BASED ON DPP IV INHIBITORS
WO2005000236A3 (en) Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
ATE404206T1 (en) ORAL SUSPENSION WITH MELOXICAM
NZ577392A (en) Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
EP2203169A4 (en) Glycemic control, diabetes treatment, and other treatments with acetyl cholinesterase inhibitors
WO2008152822A1 (en) Medicinal agent
IL186426A0 (en) Use of nefopam and analogues thereof for the treatment of a syndrome characterised by chronic pain and fatigue
EP1959728A4 (en) Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
WO2007137224A3 (en) Method of treatment
DK1869185T3 (en) Conjugate with P21 protein for cancer treatment
NZ587670A (en) Use of interleukin-1 conjugates in the treatment of diabetes
MX2009001433A (en) Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy.
UA10952U (en) Method for correcting disorders of microcirculation and hemostasis in patients with chronic steatohepatitis with insulin resistance syndrome
NO20080495L (en) PEG-IFN-alpha and ribavirin for HBV treatment
WO2007009704A3 (en) Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes
陈刚 An Apple a Day
UA35032U (en) Method of immunorehabilitation of patients with posthepatic syndrome upon acute viral hepatitis
UA33211U (en) Method for treating patients with syndrome of increased fatigue in setting of chronic hepatobiliary pathology
MY155041A (en) Methods and dosage forms for reducing side effects of benzisozazole derivatives
TW200638936A (en) Methods and dosage forms for reducing side effects of benzisoxazole derivatives
UA34811U (en) Method for correcting cytokine state in patients with non-alcoholic steatohepatitis
UA34817U (en) Method for medical rehabilitation of patients with syndrome of increased fatigue with concomitant chronic tonsillitis